Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
US OptionsDetailed Quotes
XBI250509P74000
- 0.07
- -0.32-82.05%
15min DelayClose May 5 16:00 ET
0.07High0.07Low
0.07Open0.39Pre Close1 Volume6 Open Interest74.00Strike Price7.00Turnover61.75%IV10.55%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.0340Delta0.0148Gamma1180.71Leverage Ratio-0.0435Theta-0.0003Rho-40.12Eff Leverage0.0062Vega
SPDR S&P Biotech ETF Newsroom
Earnings Call Summary | Neurocrine Biosciences(NBIX.US) Q1 2025 Earnings Conference
Earnings Call Summary | Vertex Pharmaceuticals(VRTX.US) Q1 2025 Earnings Conference
Vertex Misses on Both Lines in Q1 as 2025 Revenue Forecast Narrowed
12 Health Care Stocks Moving In Monday's After-Market Session
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance
Neurocrine Biosciences Non-GAAP EPS of $0.70 Misses by $0.39, Revenue of $572.6M Beats by $11.63M
Vertex Pharmaceuticals Non-GAAP EPS of $4.06 Misses by $0.23, Revenue of $2.77B Misses by $90M
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
10 Health Care Stocks Whale Activity In Today's Session
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Here Are the Major Earnings After the Close Today
Earnings Scheduled For May 5, 2025
Vertex Pharmaceuticals Q1 2025 Earnings Preview
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
Gilead and Vertex Pharma Named Among Biotech's Tariff Safe Havens
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now